Status:
RECRUITING
Yoga Nidra for Insomnia and Posttraumatic Stress Symptoms
Lead Sponsor:
University College, London
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Posttraumatic Stress Disorder (PTSD)
Insomnia
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
This randomized feasibility study is designed to investigate the feasibility of recruitment and delivery of two variations (brief; full) of a virtual Integrative Restoration (iRest) yoga nidra meditat...
Detailed Description
Participants will be randomly assigned to 1 of three groups: two remote yoga nidra interventions will be compared to a waitlist control group. The yoga nidra groups will be as follows: a high-dose con...
Eligibility Criteria
Inclusion
- Endorses experiencing at least one lifetime very stressful or traumatic event that still distresses them
- Score of 13 or higher on the 8-item PCL-5
- Scoring 15 or higher on the Insomnia Severity Index, indicating the presence of moderate to severe insomnia
- Being able and willing to listen to online yoga nidra audio recordings that may each be up to 35 minutes long daily for 8 weeks
- Being willing to monitor sleep and PTSD symptoms for 10 weeks
- Normal or corrected to normal hearing and vision
- Fluent in English
- Reliable daily access to the internet Between the ages of 18 and 35
- Between the ages of 18 and 35
- Reliable daily access to the internet
- Willing to refrain from ingesting caffeine, alcohol, and recreational drugs the day of the sleep studies
- Currently receiving or seeking treatment for alcoholism or a substance abuse disorder
Exclusion
- History of schizophrenia, psychotic disorder, or bipolar disorder
- Current endorsement of suicidality (score of 2 or higher on Item 9 of the BDI-II)
- Currently receiving psychological treatment for any mental health disorder
- Current diagnosis of any sleep disorder, excluding insomnia or nightmare disorder
- Currently taking benzodiazepines, nonbenzodiazepine receptor agonists, orexin agonists or antagonists, antiseizure medication, any medications for sleep
- Score of 5 or higher on STOP-BANG Questionnaire (indicating likelihood of moderate to severe obstructive sleep apnea)
- Previous adverse experience with meditation
- Current regular meditative practice (meditating once or more per month)
Key Trial Info
Start Date :
March 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06888336
Start Date
March 3 2025
End Date
November 1 2025
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London
London, United Kingdom